Alzheimer’s disease (AD) shows various symptoms that reflect cognitive impairment and loss of neural circuit integrity. Sensory dysfunctions such as olfactory and ocular pathology are also observed and used as indicators for early detection of AD. Although mastication is suggested to correlate with AD progression, changes in the masticatory system have yet to be established in transgenic animal models of AD. In the present study, we have assessed pathologic hallmarks of AD with the masticatory behavior of 5XFAD mice. We found that masticatory efficiency and maximum biting force were decreased in 5XFAD mice, with no significant change in general motor function. Immunohistochemical analysis revealed significant accumulation of Aβ (amyloid β), increased microglia number, and cell death in Vmo (trigeminal motor nucleus) as compared with other cranial motor nuclei that innervate the orofacial region. Masseter muscle weight and muscle fiber size were also decreased in 5XFAD mice. Taken together, our results demonstrate that Aβ accumulation in Vmo contributes to masticatory dysfunction in 5XFAD mice, suggesting a close association between masticatory dysfunction and dementia.
ButterfieldSMLashuelHA. 2010. Amyloidogenic protein–membrane interactions: mechanistic insight from model systems. Angew Chem Int Ed. 49(33):5628–5654.
2.
CamposCHRibeiroGRCostaJLRodrigues GarciaRC. 2017. Correlation of cognitive and masticatory function in Alzheimer’s disease. Clin Oral Investig. 21(2):573–578.
3.
Cerutti-KopplinDFeineJPadilhaDDe SouzaRAhmadiMRompréPBooijLEmamiE.2016. Tooth loss increases the risk of diminished cognitive function: a systematic review and meta-analysis. JDR Clin Trans Res. 1(1):10–19.
4.
ChatterjeeMFaotFCorreaCDuyckJNaertIVandammeK.2017. A robust methodology for the quantitative assessment of the rat jawbone microstructure. Int J Oral Sci. 9(2):87–94.
5.
ChuT-HCumminsKSparlingJSTsutsuiSBrideauCNilssonKPRJosephJTStysPK. 2017. Axonal and myelinic pathology in 5XFAD Alzheimer’s mouse spinal cord. PLoS One. 12(11):e0188218.
6.
DeviLOhnoM.2010. Phospho-eiF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PLoS One. 5(9):e12974.
7.
DeweerBLehericySPillonBBaulacMChirasJMarsaultCAgidYDuboisB.1995. Memory disorders in probable Alzheimer’s disease: the role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry. 58(5):590–597.
8.
EimerWAVassarR.2013. Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and caspase-3 activation. Mol Neurodegener. 8:2.
9.
FrostSMartinsRNKanagasingamY.2010. Ocular biomarkers for early detection of Alzheimer’s disease. J Alzheimers Dis. 22(1):1–16.
10.
GrimaldiABrighiCPeruzziGRagozzinoDBonanniVLimatolaCRuoccoGDi AngelantonioS.2018. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer’s disease in the 3xTg-AD mouse model. Cell Death Dis. 9(6):685.
11.
GrünheidTLangenbachGEKorfageJAZentnerAVan EijdenTM. 2009. The adaptive response of jaw muscles to varying functional demands. Eur J Orthod. 31(6):596–612.
12.
HeZGuoJLMcBrideJDNarasimhanSKimHChangolkarLZhangBGathaganRJYueCDenglerC.2018. Amyloid-β plaques enhance Alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 24(1):29–38.
13.
HossainMIHorieMYoshiokaNKuroseMYamamuraKTakebayashiH.2018. Motoneuron degeneration in the trigeminal motor nucleus innervating the masseter muscle in dystonia musculorum mice. Neurochem Int. 119:159–170.
14.
KarlssonSCarlssonGE. 1990. Characteristics of mandibular masticatory movement in young and elderly dentate subjects. J Dent Res. 69(2):473–476.
15.
KongLWangXChoeDWPolleyMBurnettBGBosch-MarceMGriffinJWRichMMSumnerCJ. 2009. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice.J Neurosci. 29(3):842–851.
LewisHBeherDCooksonNOakleyAPiggottMMorrisCMJarosEPerryRIncePKennyRA, et al. 2006. Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathol Appl Neurobiol. 32(2):103–118.
18.
MesholamRIMobergPJMahrRNDotyRL. 1998. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol. 55(1):84–90.
19.
NakamuraYKatakuraNNakajimaMLiuJ.2004. Rhythm generation for food-ingestive movements. Prog Brain Res. 143:97–103.
20.
OakleyHColeSLLoganSMausEShaoPCraftJGuillozet-BongaartsAOhnoMDisterhoftJVan EldikL, et al. 2006. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 26(40):10129–10140.
21.
O’KeeffeSTKazeemHPhilpottRMPlayferJRGosneyMLyeM.1996. Gait disturbance in Alzheimer’s disease: a clinical study. Age Ageing. 25(4):313–316.
22.
OnozukaMWatanabeKNagasakiSJiangYOzonoSNishiyamaKKawaseTKarasawaNNagatsuI.2000. Impairment of spatial memory and changes in astroglial responsiveness following loss of molar teeth in aged SAMP8 mice. Behav Brain Res. 108(2):145–155.
23.
OverkCRKelleyCMMufsonEJ. 2009. Brainstem Alzheimer’s-like pathology in the triple transgenic mouse model of Alzheimer’s disease. Neurobiol Dis. 35(3):415–425.
24.
ParviziJVan HoesenGWDamasioA.2001. The selective vulnerability of brainstem nuclei to Alzheimer’s disease. Ann Neurol. 49(1):53–66.
25.
PiancinoMGTortaroloAPolimeniABramantiEBramantiP.2020. Altered mastication adversely impacts morpho-functional features of the hippocampus: a systematic review on animal studies in three different experimental conditions involving the masticatory function. PLoS One. 15(8):e0237872.
26.
RosenWGMohsRCDavisKL. 1984. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 141(11):1356–1364.
27.
SakumaKYamaguchiA.2018. Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia. Pflügers Arch. 470(3):449–460.
28.
SimanRCardJDavisL.1990. Proteolytic processing of beta-amyloid precursor by calpain I. J Neurosci. 10(7):2400–2411.
29.
SinghSMishraAMohanbhaiSJTiwariVChaturvediRKKhuranaSShuklaS.2018. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson’s disease. Free Radic Biol Med. 129:73–87.
30.
SinghraoSKHardingASimmonsTRobinsonSKesavaluLCreanS.2014. Oral inflammation, tooth loss, risk factors, and association with progression of Alzheimer’s disease. J Alzheimers Dis. 42(3):723–737.
31.
TerryRDMasliahESalmonDPButtersNDeTeresaRHillRHansenLAKatzmanR.1991. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 30(4):572–580.
TraversJB. 2015. Oromotor nuclei. In: PaxinosG editor. The rat nervous system. Elsevier. Chapter 11, p. 223–245.
34.
UematsuMNakamuraAEbashiMHirokawaKTakahashiRUchiharaT.2018. Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β. Acta Neuropathol Commun. 6(1):1.
35.
YooS-JLeeJ-HKimSYSonGKimJYChoBYuS-WChangK-ASuhY-HMoonC.2017. Differential spatial expression of peripheral olfactory neuron-derived bace1 induces olfactory impairment by region-specific accumulation of β-amyloid oligomer. Cell Death Dis. 8(8):e2977.
36.
YuanPGrutzendlerJ.2016. Attenuation of β-amyloid deposition and neurotoxicity by chemogenetic modulation of neural activity. J Neurosci. 36(2):632–641.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
